Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The management of adolescents living with HIV represents a particular challenge in the global response to HIV. The challenges specific to this age group include difficulties engaging and maintaining them in care, challenges with transition to adult care, and limited therapeutic options for treatment-experienced patients, all of which have been jeopardized by the COVID-19 pandemic. This paper summarizes some of the challenges in managing adolescents living with HIV, as well as some of the most recent and innovative therapeutic approaches in this population.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611287PMC
http://dx.doi.org/10.3390/v15102023DOI Listing

Publication Analysis

Top Keywords

adolescents living
12
living hiv
12
gen hiv-strategies
4
hiv-strategies optimizing
4
optimizing care
4
care generation
4
generation adolescents
4
hiv
4
hiv management
4
management adolescents
4

Similar Publications

A community-based qualitative study identified multilevel influences on sleep duration, quality, and timing in 10 to 12-year-old Latino pre-adolescents via 11 focus groups with 46 children and 15 interviews with parents. An iterative content analysis revealed three themes negatively and positively impacted sleep: (1) Individual-level; (2) Social-level; and (3) Environmental-level influences. At the individual level, use of technology (e.

View Article and Find Full Text PDF

Global prevalence, incidence and years lived with disability of polycystic ovary syndrome highlights disease burden among adolescents.

Reprod Biomed Online

May 2025

Department of Obstetrics and Gynaecology, and Neonatology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Centre for Obstetrics and Gynaecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Med

Research Question: What is the global, regional and national burden of polycystic ovary syndrome (PCOS), particularly in adolescents, based on data from the Global Burden of Disease (GBD) 2021 study?

Design: Prevalence, incidence and years lived with disability (YLD) for PCOS were extracted from the GBD 2021 database, standardized via Bayesian meta-regression, and stratified by age, region and Socio-Demographic Index (SDI). Temporal trends (1990-2021) were presented, and future projections (to 2045) were modelled using autoregressive integrated moving average models.

Results: Between 1990 and 2021, the global prevalence of PCOS increased from 36.

View Article and Find Full Text PDF

Excess mortality and disease burden due to conflict in Gaza: focus on the 0-14 age group.

Turk J Pediatr

September 2025

Department of Public Health, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Türkiye.

Background: The ongoing conflict in Gaza continues to take an unbearable toll, with particularly severe impacts on children. Measuring the burden of conflict-related disease in Gaza in terms of disability-adjusted life years (DALYs) is important in terms of showing this effect. The aim of this study was to calculate the conflict-related DALY in Gaza among children aged 0-14 years, following the October 7 events and compare these values with global and expected values.

View Article and Find Full Text PDF

Background: Despite advances in HIV care, viral load suppression (VLS) among adolescents living with HIV (ALHIV) in Uganda continue to lag behind that of adults, even with the introduction of dolutegravir (DTG)-based regimens, the Youth and Adolescent Peer Supporter (YAPS) model, and community-based approaches. Understanding factors associated with HIV viral load non-suppression in this population is critical to inform HIV treatment policy. This study assessed the prevalence and predictors of viral load non-suppression among ALHIV aged 10-19 years on DTG-based ART in Soroti City, Uganda.

View Article and Find Full Text PDF

Background: Hepatitis C virus (HCV) and injection drug use among young women are dramatically rising in the rural United States. From 2004 to 2017, heroin use among non-pregnant women increased 22.4% biennially, mirroring increases in HCV cases, especially among younger populations.

View Article and Find Full Text PDF